V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20223936 | 20084817 | 1.69 | 70.6 | Curative (C) | 2017-12-06 | 2018-01-01 | Capecitabine + Cisplatin + RT | 02 | N | LUTETIUM-177 | 100337328 |
| 20223937 | 20084818 | 1.75 | 57.3 | Neo-adjuvant (N) | 2016-03-28 | 2016-04-19 | Enzalutamide | null | N | CETUXIMAB | 100978074 |
| 20223948 | 20084819 | 1.58 | 50.8 | null | 2018-04-18 | 2018-04-18 | Enzalutamide | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101307724 |
| 20223960 | 20084820 | 1.63 | 87.9 | Curative (C) | 2018-11-14 | 2018-11-14 | Enzalutamide | 02 | Y | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100416305 |
| 20223966 | 20084821 | 1.63 | 51.5 | Curative (C) | null | 2018-01-26 | Mitomycin Intravesical | 02 | null | MITOMYCIN INTRAVESICULAR | 100457119 |
| 20223978 | 20084822 | 1.69 | 83.9 | Neo-adjuvant (N) | 2019-10-13 | 2019-11-23 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 100936578 |
| 20223979 | 20084823 | 1.7 | 71 | Neo-adjuvant (N) | 2016-02-20 | 2016-02-21 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 101606882 |
| 20223993 | 20084824 | 1.63 | 108 | Neo-adjuvant (N) | 2016-09-27 | 2016-10-02 | Cetuximab 14 day | 2 | N | CAPECITABINE + CISPLATIN + RT | 100261348 |
| 20223994 | 20084825 | 1.69 | 55.3 | Palliative (P) | 2016-12-20 | 2016-12-20 | Enzalutamide | 02 | N | TRASTUZUMAB | 100619750 |
| 20223995 | 20084826 | 1.6 | 48.5 | Palliative (P) | 2017-06-19 | 2017-07-10 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100541976 |
| 20224003 | 20084827 | 1.59 | 62.2 | Palliative (P) | 2012-10-30 | 2019-02-14 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101534043 |
| 20224010 | 20084828 | 1.77 | 54.8 | Palliative (P) | 2019-09-29 | 2019-09-29 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100465964 |
| 20224014 | 20084829 | 1.8 | 66 | Neo-adjuvant (N) | 2017-03-01 | 2017-03-08 | Oxaliplatin + Raltitrexed | N | Y | OXALIPLATIN + RALTITREXED | 101212001 |
| 20224015 | 20084830 | 1.63 | 62 | Palliative (P) | 2018-03-01 | 2018-03-01 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100839151 |
| 20224017 | 20084831 | 1.76 | null | 03 | 2016-08-09 | 2016-08-22 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100484714 |
| 20224020 | 20084832 | 1.76 | 70.1 | Curative (C) | 2019-01-13 | 2019-01-27 | Enzalutamide | 02 | Y | ENZALUTAMIDE | 101013899 |
| 20224025 | 20084833 | 0 | 0 | Curative (C) | 2018-01-07 | 2018-01-21 | Enzalutamide | 02 | N | CISPLATIN | 101367043 |
| 20224027 | 20084834 | 1.58 | null | Curative (C) | 2022-02-16 | 2022-03-08 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 101095591 |
| 20224028 | 20084835 | 0 | 70.9 | Neo-adjuvant (N) | 2018-03-24 | 2018-03-24 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100260228 |
| 20224037 | 20084836 | null | 125 | Disease modification (D) | 2018-05-28 | 2018-06-13 | Enzalutamide | N | null | ENZALUTAMIDE | 101596662 |
| 20224039 | 20084837 | 1.56 | 75 | Palliative (P) | 2018-11-21 | 2018-12-03 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 101605438 |
| 20224042 | 20084838 | 1.7 | 51 | Palliative (P) | 2019-11-21 | 2019-12-21 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 100756543 |
| 20224059 | 20084839 | 1.7 | 135.5 | Palliative (P) | 2017-04-30 | 2017-04-30 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 100435869 |
| 20224062 | 20084840 | 1.67 | 65 | Curative (C) | 2017-02-08 | 2017-02-16 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 101108634 |
| 20224082 | 20084841 | 1.45 | 58.3 | Palliative (P) | 2019-12-20 | 2020-01-03 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100679750 |
| 20224087 | 20084842 | 1.76 | 75.3 | Palliative (P) | 2018-09-14 | 2018-09-22 | Enzalutamide | 02 | N | ENZALUTAMIDE | 100971602 |
| 20224088 | 20084843 | 1.71 | null | Palliative (P) | 2019-10-04 | 2019-10-08 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100864181 |
| 20224092 | 20084844 | 1.53 | 90 | Palliative (P) | 2018-07-01 | 2018-07-19 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100649668 |
| 20224093 | 20084845 | 1.58 | 61 | Palliative (P) | 2016-02-18 | 2016-02-19 | Enzalutamide | null | N | CARBOPLATIN + GEMCITABINE | 101773600 |
| 20224096 | 20084846 | 1.79 | 83.9 | null | 2017-03-14 | 2017-03-15 | Enzalutamide | 02 | null | CETUXIMAB + OXALIPLATIN + MDG | 100687106 |
| 20224102 | 20084847 | 1.65 | 55.4 | Palliative (P) | 2016-07-30 | 2016-08-17 | Enzalutamide | 02 | null | ECF | 100164287 |
| 20224104 | 20084848 | null | 55.2 | Palliative (P) | 2018-07-02 | 2018-07-02 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 101301210 |
| 20224105 | 20084849 | 1.51 | 91 | Palliative (P) | 2019-03-14 | 2019-03-18 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 100751236 |
| 20224106 | 20084850 | 0 | 0 | Curative (C) | null | 2018-08-02 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101023786 |
| 20224107 | 20084851 | 1.81 | 73 | Curative (C) | 2018-09-08 | 2018-09-12 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100813477 |
| 20224117 | 20084852 | 1.48 | 51.5 | Curative (C) | 2019-11-01 | 2019-11-21 | Capecitabine + Cisplatin + RT | N | Y | CAPECITABINE + CISPLATIN + RT | 101789810 |
| 20224119 | 20084853 | 1.69 | 64.7 | Palliative (P) | 2016-08-02 | 2016-08-02 | Enzalutamide | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100477891 |
| 20224126 | 20084854 | 1.78 | 71.6 | null | 2018-05-09 | 2018-05-09 | Enzalutamide | 02 | null | CETUXIMAB | 100282984 |
| 20224127 | 20084855 | 1.58 | 59.5 | Palliative (P) | 2019-08-18 | 2019-09-01 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101665721 |
| 20224132 | 20084856 | 1.77 | 71.9 | Palliative (P) | 2019-07-16 | 2019-07-16 | Enzalutamide | 02 | N | LUTETIUM-177 | 100734205 |
| 20224142 | 20084857 | 1.69 | 80.2 | null | 2019-12-19 | 2019-12-19 | Capecitabine + Cisplatin + RT | 02 | null | CARBOPLATIN + GEMCITABINE | 100619164 |
| 20224144 | 20084858 | 1.56 | 106 | null | 2019-05-22 | 2019-05-22 | Enzalutamide | 02 | null | CISPLATIN | 101730793 |
| 20224146 | 20084859 | 1.56 | 87 | Adjuvant (A) | 2018-02-02 | 2018-02-17 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 101321462 |
| 20224154 | 20084860 | 1.51 | 102.4 | Palliative (P) | 2018-04-21 | 2018-04-21 | Enzalutamide | 02 | N | ENZALUTAMIDE | 101564498 |
| 20224162 | 20084861 | 1.62 | 75.4 | Palliative (P) | 2016-10-12 | 2016-10-12 | CARBOPLATIN + PACLITAXEL + RT | 02 | Y | CAPECITABINE + TEMOZOLOMIDE | 100987406 |
| 20224165 | 20084862 | 1.58 | 66 | Palliative (P) | 2019-11-12 | 2019-11-19 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 100084949 |
| 20224166 | 20084863 | 1.67 | 169.3 | Palliative (P) | 2018-07-28 | 2018-08-14 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 101191202 |
| 20224175 | 20084864 | null | 71.5 | Curative (C) | 2019-05-04 | 2019-05-11 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 101836552 |
| 20224179 | 20084865 | 1.66 | 87.05 | Palliative (P) | 2016-02-24 | 2016-03-01 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 101288026 |
| 20224181 | 20084866 | 1.56 | 45 | Palliative (P) | 2017-03-04 | 2017-03-07 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101086768 |